Plant-based Covid-19 vaccine developer Medicago laying off 60+ at North Carolina plant

Paul Schloesser

Associate Editor

Medicago had been looking at, among other things, a plant-based vaccine for Covid-19. But those plans aren’t going in the direction Medicago wanted to. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Plant-based Covid-19 vaccine developer Medicago laying off 60+ at North Carolina plant

Paul Schloesser

Associate Editor

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA approves first drug to treat ultra-rare lipid storage disease

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Plant-based Covid-19 vac­cine de­vel­op­er Med­ica­go lay­ing off 60+ at North Car­oli­na plant

Associate Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Plant-based Covid-19 vaccine developer Medicago laying off 60+ at North Carolina plant